| # | Drug | Count |
|---|---|---|
| 0 | OMALIZUMAB | 740 |
| 1 | CETIRIZINE HYDROCHLORIDE | 227 |
| 2 | CETIRIZINE | 210 |
| 3 | PREDNISONE | 210 |
| 4 | CYCLOSPORINE | 196 |
| 5 | MONTELUKAST | 161 |
| 6 | MONTELUKAST SODIUM | 157 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 142 |
| 8 | CETIRIZINE HYDROCHLORIDE ALLERGY | 124 |
| 9 | CETIRIZINE HYDROCHLORIDE TABLETS | 124 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMALIZUMAB | 740 | 0.0085 |
| 1 | CETIRIZINE HYDROCHLORIDE TABLETS | 124 | 0.0040 |
| 2 | CETIIRIZINE | 97 | 0.0022 |
| 3 | HYDROXYZINE | 104 | 0.0021 |
| 4 | CYCLOSPORINE | 196 | 0.0017 |
| 5 | LORATADINE TABLET | 76 | 0.0014 |
| 6 | CETIRIZINE HYDROCHLORIDE | 227 | 0.0014 |
| 7 | MONTELUKAST SODIUM | 157 | 0.0013 |
| 8 | LORATADINE | 100 | 0.0009 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 142 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-IgE [EPC] | 742 |
| 1 | Corticosteroid [EPC] | 332 |
| 2 | Calcineurin Inhibitor Immunosuppressant [EPC] | 205 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 126 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 124 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 75 |
| 6 | Benzodiazepine [EPC] | 70 |
| 7 | Proton Pump Inhibitor [EPC] | 67 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 63 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 49 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | Anti-IgE [EPC] | 742 | 0.0085 |
| 2 | Sulfone [EPC] | 35 | 0.0032 |
| 3 | Allylamine Antifungal [EPC] | 12 | 0.0017 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 205 | 0.0016 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 124 | 0.0015 |
| 6 | mu-Opioid Receptor Agonist [EPC] | 4 | 0.0014 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 39 | 0.0013 |
| 8 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 17 | 0.0010 |